HIV/AIDS Therapy
Studies advance knowledge in HIV/AIDS therapy research
Published in Drug Week, April 28th, 2006
Study 1: Scientists are investigating the use of a strategy of HIV treatment interruption based on CD4+ cell counts.
Researchers in Italy conducted a study to "evaluate the safety of treatment interruption (TI) guided by CD4+ count in HIV-infected patients followed-up prospectively."
A. Boschi and colleagues at AUSL Rimini explained, "Patients on HAART with a CD4+ cell count >500 cells/mm3 discontinued therapy with instructions to start therapy again before their CD4+ count dropped below 200 cells/mm3. We...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Week
Source: Drug Week (2006-04-28)
More Articles from Drug Week
- Drug Development
Nitric oxide-donating aspirin is focus of review of pharmacological and clinical perspectives - Drug Development
Paclitaxel efficacy enhanced by novel compound 73R - Drug Development
Rifamycin-resistant Staphylococcus aureus susceptible to novel rifamycins - HIV/AIDS HAART
HAART discontinuation risk factors identified - Melanoma Therapy
Preclinical results support continued evaluation of CR011-vcMMAE for melanoma - Acid Reflux
Gastroesophageal acid reflux Rennie alginate treatment promising - More from this issue of Drug Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
